Jae-eun Miller, PhD

  • Assistant Professor of Neurobiology (in Psychiatry)
Profile Headshot

Overview

Dr. Miller received her Ph.D. from Washington University in St. Louis, where she worked with Dr. David Holtzman and made a seminal discovery that the sleep-wake cycle regulates amyloid-beta levels in humans and mice. She then conducted postdoctoral research with Dr. Rafael Yuste in the Department of Biological Sciences at Columbia University, where she studied the role of intrinsic neuronal ensembles in visual perception using advanced optical imaging and neuronal manipulation technologies. Dr. Miller received a K99/R00 Pathway to Independence Award from the NIH. Since 2021, she has been an independent investigator in the Department of Psychiatry at Columbia University where she applies in vivo imaging and circuit manipulation to investigate the pathophysiology of Alzheimer’s disease.

Academic Appointments

  • Assistant Professor of Neurobiology (in Psychiatry)

Gender

  • Female

Credentials & Experience

Education & Training

  • BS, 2000 Biology, Kyunghee University
  • MS, 2003 Biochemistry, Younsei University
  • PhD, 2009 Neuroscience, Washington University in St Louis

Research

The Miller Laboratory investigates how Alzheimer’s disease pathology leads to disrupted sleep–wake patterns and memory loss, two early symptoms of the disease. By determining the molecular and neural-circuit mechanisms underlying the disrupted sleep-wake patterns and memory loss, the team aims to develop new therapeutic approaches to prevent and reverse these core symptoms, delay the disease, and ultimately promote healthy aging.

Alzheimer’s disease causes devastating memory impairment. This core symptom is likely due to a breakdown in neural computation, particularly in the entorhinal cortex-hippocampal circuit in early stage of the disease. Successful treatments must address this computational breakdown. However, it is unknown how computation deteriorates during learning and memory in Alzheimer’s disease. We know many of the molecular-cellular drivers of disease, and we know the ruinous consequences for people’s lives, but the process connecting these - entorhinal-hippocampal computation - is poorly understood. Using mouse models, her team aims to determine how neural computation breaks down and develop methods to reverse this.

Circadian sleep-wake rhythm declines with aging, causing fragmented sleep, difficulty sleeping at night, and difficulty staying awake during the day. Disrupted sleep increases the risk of many age-related diseases, particularly Alzheimer's disease, which in turn worsens sleep, a feedback loop that accelerates neurodegeneration. Breaking this cycle by restoring sleep rhythm in aging could have widespread health benefits. Using mouse models of aging and Alzheimer's disease, the Miller Laboratory aims to determine how circadian sleep-wake rhythms are regulated in the healthy brain and how this regulation deteriorates with aging and disease.

Across these research areas, the Miller Laboratory combines in vivo calcium imaging with neuronal and genetic manipulation to uncover the molecular and circuit-level mechanisms underlying memory loss and circadian sleep-wake dysfunction. Its mission is to translate these discoveries into therapeutic strategies that restore healthy brain function.

Research Interests

  • Aging
  • Brain Imaging
  • circadian rhythms
  • Neurobiology of Disease
  • Neurobiology of Learning and Memory
  • Sleep
  • Systems and Circuits

Grants

  • 2026: NIA 1R01AG086475

  • 2025: BrightFocus Alzheimer’s Disease Research Award, BrightFocus Foundation

  • 2025: Alzheimer’s Association Research Award, Alzheimer’s Association

  • 2024: Healthy Aging Pilot Award, Robert N. Butler Columbia Aging Center

  • 2023: Junior Faculty Award, Columbia University Provost

  • 2022: Director’s Award, Columbia University Irving Medical Center

  • 2019: Alzheimer’s Disease Research Center Pilot Grant Award, Columbia University Irving Medical Center

  • 2014: K99/R00 Pathway to Independence Award, NIH/NEI

  • 2013: Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship, NIH/NEI

  • 2010: David M. Kipnis Award for Human Disease Research, Washington University

  • 2009: Barbara Jakschik Award for Metabolic Disease Research, Washington University

  • 2007: Alzheimer’s Disease Research Center Director’s Award, Washington University

Selected Publications

Selected Publications

  1. Miller JK, Miller BR, O’Neil DA, Yuste R. An increase in spontaneous activity mediates visual habituation. Cell Reports. 2022;39(4):110751
  2. Karimipanah Y, Ma Z, Miller JK, Yuste R, Wessel R. Neocortical activity is stimulus- and scale-invariant. PLoS One. 2017;12(5):e0177396
  3. Yang W, Miller JE, Carrillo-Reid L, Pnevnatikskis E, Paninski L, Yuste R, Peterka D. Simultaneous multi-plane imaging of neural circuits. Neuron. 2016;89(2):269–284
  4. Carrillo-Reid L, Miller JE, Hamm JP, Jackson J, Yuste R. Visual stimulation triggers endogenous sequential activity patterns in the primary visual cortex. Journal of Neuroscience. 2015;35(23):8813–8828
  5. Miller JE, Ayzenshtat I, Carrillo-Reid L, Yuste R. Visual stimuli recruit intrinsically generated cortical ensembles. Proceedings of the National Academy of Sciences of the United States of America 2014;111(38):E4053–E4061
  6. Miller JE, Granados-Fuentes D, Wang T, Marpegan L, Holy TE, Herzog ED. Vasoactive intestinal polypeptide mediates circadian rhythms in mammalian olfactory bulb and olfaction. Journal of Neuroscience. 2014;34(17):6040–6046
  7. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005–1007
  8. Cirrito JR, Kang JE, Lee JY, Stewart FR, Bu G, Mennerick S, Holtzman DM. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008;58(1):42–51
  9. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM. Acute stress increases interstitial fluid amyloid-beta via corticotrophin releasing factor (CRF) and neuronal activity. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(25):10673–10678

Back to top